Fig. 5
From: Quantitative multiparametric MRI predicts response to neoadjuvant therapy in the community setting
Mean tumor ADC (A) is relatively stable over the course of NAT while the median tumor Ktrans (B) tends to decline over the course of NAT. Patients who achieved a pCR are shown in red in Panels A and B. Significant differences in the relative change in ADC from baseline (C) were observed between patients who achieved pCR and those who did not achieve pCR at the third and fourth MRI. Significant differences in the relative change in Ktrans from baseline (D) were also observed between patients who achieved pCR and those who did not achieve pCR at the third and fourth MRI (*p < 0.05; **p < 0.01; ***p < 0.001)